GCGerald R. Cunha

Gerald R. Cunha

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gerald R. Cunha has a total of 60 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Spatial transcriptomics identifies candidate stromal drivers of benign prostatic hyperplasia

    by Anna S. Pollack, Christian A. Kunder, Noah Brazer, Zhewei Shen, Sushama Varma, Robert B. West, Gerald R. Cunha, Laurence S. Baskin, James D. Brooks, Jonathan R. Pollack

    Benign prostatic hyperplasia (BPH) is the nodular proliferation of the prostate transition zone in older men, leading to urinary storage and voiding problems that can be recalcitrant to therapy. Decades ago, John McNeal proposed that BPH originates with the “reawakening” of embryonic inductive activity by adult prostate stroma, which spurs new ductal proliferation and branching morphogenesis. Here, by laser microdissection and transcriptional profiling of the BPH stroma adjacent to hyperplastic branching ducts, we identified secreted factors likely mediating stromal induction of prostate glandular epithelium and coinciding processes. The top stromal factors were insulin-like growth factor 1 ( IGF1 ) and CXC chemokine ligand 13 ( CXCL13 ), which we verified by RNA in situ hybridization to be coexpressed in BPH fibroblasts, along with their cognate receptors ( IGF1R and CXCR5 ) on adjacent epithelium. In contrast, IGF1 but not CXCL13 was expressed in human embryonic prostate stroma. Finally, we demonstrated that IGF1 is necessary for the generation of BPH-1 cell spheroids and patient-derived BPH cell organoids in 3D culture. Our findings partially support historic speculations on the etiology of BPH and provide what we believe to be new molecular targets for rational therapies directed against the underlying processes driving BPH.


  • Open Access

    Steroid hormones stimulate human prostate cancer progression and metastasis

    by William A. Ricke, Kenichiro Ishii, Emily A. Ricke, Jeff Simko, Yuzhuo Wang, Simon W. Hayward, Gerald R. Cunha

    Tissue recombinants (TRs) composed of mouse urogenital mesenchyme (mUGM) plus an immortalized nontumorigenic human prostatic epithelial cell line (BPH‐1) were grown under the kidney capsule of male athymic nude mice under different hormonal conditions. The objectives were to determine temporal plasma concentrations of testosterone (T) and estradiol‐17β (E2) that elicit progression of nontumorigenic human prostatic epithelial cells in vivo. Second, to determine whether mUGM+BPH‐1 TRs in [T+E2]‐treated hosts could progress to metastases. Control mouse hosts received no exogenous hormonal support, whereas treated mice received Silastic implants containing T and E2 for 1–4 months. Plasma from hormonally treated mice contained significantly higher (p < 0.01) concentrations of T at 1 month (11.7 vs. 0.9 ng/ml). Plasma levels of E2 in steroid implanted mice were significantly higher (p vs. 25.6 ng/l) and 4 months (122.8 vs. 19.2 pg/ml). Wet weights of mUGM+BPH‐1 TRs from [T+E2]‐implanted mice were significantly larger (p < 0.001) than those from untreated hosts. Untreated mUGM+BPH‐1 TRs contained a well organized differentiated epithelium surrounded by smooth muscle stroma similar to developing prostate. In [T+E2]‐implanted mice, mUGM+BPH‐1 TRs formed carcinomas that contained a fibrous connective tissue stroma permeating the tumor; smooth muscle when present was associated with vasculature. Renal lymph nodes collected from [T+E2]‐treated mice, but not untreated mice, contained metastatic carcinoma cells. Moreover, metastases could be observed at distant sites including lung and liver. Epithelial cells isolated from untreated mUGM+BPH‐1 TRs exhibited benign histology and formed small nontumorigenic grafts when subsequently transplanted into athymic nude mice. In contrast, epithelial cells isolated from mUGM+BPH‐1 tumors of [T+E2]‐treated hosts formed large tumors that grew independent of stromal and hormonal support and developed lymph node metastases. We conclude that [T+E2]‐treatment promotes prostatic cancer progression in mUGM + BPH‐1 TRs. Use of mUGM in this system will allow future studies to utilize the power of mouse genetics to identify paracrine factors involved in human prostatic carcinogenesis.


  • Open Access

    The Ontogeny of the Urogenital System of the Spotted Hyena (Crocuta crocuta Erxleben)1

    by Gerald R. Cunha, Ned J. Place, Larry Baskin, Alan Conley, Mary Weldele, Tristan J. Cunha, Y.Z. Wang, Mei Cao, Stephen E. Glickman

    Studies were conducted to elucidate the importance of androgen-mediated induction of the extreme masculinization of the external genitalia in female


  • Steroids and prostate cancer

    by G.R. Cunha, P. Tuohimaa, T. Visakorpi


  • Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development

    by Gerald R. Cunha, Will Ricke, Axel Thomson, Paul C. Marker, Gail Risbridger, Simon W. Hayward, Y.Z. Wang, Annemarie A. Donjacour, Takeshi Kurita


  • Development of the Penile Urethra

    by Gerald R. Cunha, Laurence Baskin


  • Open Access

    Role of stromal-epithelial interactions in hormonal responses

    by Gerald R. Cunha, Paul S. Cooke, Takeshi Kurita

    Steroid sex hormones (17β-estradiol, testosterone, dihydrotestosterone, and progesterone) and aryl hydrocarbons such as the dioxins regulate epithelial proliferation and secretory protein production and differentiation in their respective target organs in male and female urogenital tracts and mammary glands. Recent evidence has demonstrated that stromal-epithelial interactions are critical for mediating the effects of these molecules on epithelial cells. Our results have indicated that estradiol, testosterone, progesterone, and dioxin regulate epithelial proliferation (stimulation or inhibition) via paracrine mechanisms requiring the appropriate receptor in the stroma. The androgen receptor (AR), estrogen receptor alpha (ERα), progesterone receptor (PR), or aryl hydrocarbon receptor (AhR) in the epithelium are neither necessary nor sufficient for the regulation of epithelial proliferation. Moreover, during prostatic development, signaling through the stromal AR is required to induce prostatic epithelial identity, ductal morphogenesis and glandular differentiation. Epithelial functional differentiation is regulated in the prostate, uterus, and vagina via AR (prostate) and ERα(uterus and vagina). In these organs both epithelial and stromal steroid receptors are required for steroidal regulation of certain aspects of epithelial differentiation such as epithelial secretory protein production in the uterus and epithelial cornification in the vagina and prostate (squamous metaplasia). The mechanistic basis of these stromal-epithelial interactions is poorly understood, but growth factors appear to be mediators of these cell-cell interactions.


  • Cellular and molecular mechanisms of development of the external genitalia

    by Gen Yamada, Yoshihiko Satoh, Laurence S. Baskin, Gerald R. Cunha


  • Role of the stromal microenvironment in carcinogenesis of the prostate

    by Gerald R. Cunha, Simon W. Hayward, Y.Z. Wang, William A. Ricke

    The topic of this review is the role of stromal‐epithelial interactions in normal and malignant prostatic growth. Because cell‐cell interactions and androgens play such key roles in the prostate, the goal of this review will be to apply endocrinologic and developmental concepts to the understanding of normal and malignant prostatic growth. Prostatic development is induced by androgens, which act via androgen receptors. Androgens elicit prostatic epithelial growth during fetal and prepubertal periods, and in adulthood androgens act via reciprocal homeostatic stromal‐epithelial interactions to maintain functional differentiation and growth quiescence. During carcinogenesis, these reciprocal homeostatic stromal‐epithelial interactions are disrupted. In this review, 2 models of prostatic carcinogenesis will be reviewed, both of which emphasize the role of the stromal microenvironment in the carcinogenic process. Hormonal carcinogenesis of the prostate can be elicited by treatment of rats and mice with testosterone plus estradiol (T+E2). Using an immortalized but nontumorigenic human prostatic epithelial cell line (BPH‐1), tissue recombinant studies were employed to explore the cellular mechanisms of prostatic carcinogenesis. Accordingly, human BPH‐1 prostatic epithelial cells were combined with rat UGM, and the resultant UGM+BPH–1 recombinants were grown in adult male nude mouse hosts. In untreated mouse hosts, UGM+BPH–1 recombinants produced solid branched epithelial cords and ductal structures exhibiting benign growth. In T+E2‐treated hosts, UGM+BPH–1 recombinants formed invasive carcinomas. Since BPH‐1 cells lack androgen and estrogen receptors, whereas rat UGM expresses both of these receptors, it is proposed that hormonal carcinogenesis is elicited by T+E2 via paracrine mechanisms mediated by the stromal microenvironment. During prostatic carcinogenesis in rats and humans, the periepithelial stroma undergoes progressive loss in smooth muscle with the appearance of carcinoma‐associated fibroblasts (CAFs). This abnormal stroma was shown to promote carcinogenesis in genetically abnormal but nontumorigenic epithelial cells. CAF+BPH‐1 tissue recombinants grown in male hosts formed carcinomas, whereas benign growth and orderly tissue architecture developed in recombinants composed of normal prostatic stroma+BPH‐1. Malignant transformation triggered by CAF was associated with additional genetic alterations and changes in gene expression in the BPH‐1 cells. Thus, the stromal microenvironment is a critical determinant of benign versus malignant growth.